Clinical Trials Browser

Phase 1 × Hematopoietic and Lymphatic System Neoplasm × Practice Guidelines as Topic × Clear all

NCT07025538 2026-02-23

Biomarker-Guided Ruxolitinib for the Prevention of Chronic Graft Versus Host Disease After Allogeneic Hematopoietic Cell Transplantation

Phase 1 Suspended

Hematopoietic and Lymphatic System Neoplasm